# Spironolactone in Diabetic Nephropathy

> **NCT00317954** · PHASE4 · COMPLETED · sponsor: **Steno Diabetes Center Copenhagen** · enrollment: 48 (—)

## Conditions studied

- Diabetic Nephropathy

## Interventions

- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT00317954
- **Lead sponsor:** Steno Diabetes Center Copenhagen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 48 (—)
- **Last updated:** 2006-04-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00317954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00317954, "Spironolactone in Diabetic Nephropathy". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00317954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*